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Introduction
Initial public offerings (IPOs) have received a lot of attention from both academic researchers and practitioners, with the attention focusing on underpricing, hot issue markets, and long-run performance (see, for example, Ritter and Welch (2002) for a recent review).
Non-redundant financial assets can help improve the completeness of financial markets and risk sharing among investors (see Huang and Litzenberger (1988) and Ingersoll (1987) ).
Thus, whether adding IPO stocks as a new asset class to the financial markets can significantly expand the minimum-variance frontier relative to already publicly traded stocks and gain substantial diversification benefits for investors or fund managers is an important and intriguing question. Our study suggests an asset allocation perspective to explore the IPO market.
The view of asset allocation is consistent with the fact that there are investment vehicles focusing on investing in IPOs. Renaissance Capital recently created a mutual fund that invests solely in IPOs, "IPO plus Aftermarket Fund" (Nasdaq symbol: IPOSX). The objective of this mutual fund is capital appreciation by investing in IPO firms, both at the offering and in the aftermarket. increased after addition of those new assets. 3 We apply portfolio selection analysis to explore the asset allocation perspective of IPOs.
The portfolio selection analysis, dating back to Markowitz (1952) , has been a standard treatment in the investment and finance textbooks. Yet, the literature has not addressed the following issues in IPO research. First, does an IPO portfolio significantly enlarge the investment opportunity set relative to currently traded stocks? To answer this question, we employ mean-variance spanning tests to examine whether adding an IPO portfolio can significantly enlarge the investment opportunity set for investors relative to a set of benchmark portfolios sorted by firm size and book-to-market ratio.
Second, to what extent is an IPO portfolio able to enlarge the mean-variance frontier?
The mean-variance spanning tests only examine whether the minimum-variance frontier expansion is statistically significant. The Sharpe ratio is the "reward to variability" ratio and measures the slope of the line from the risk-free rate to any portfolio in the mean-standard deviation plane (see Sharpe (1994) ). Bekaert and Urias (1996) suggest that one can assess the economic significance of the shift in the minimum-variance frontier by evaluating the change in the Sharpe ratio. A positive change in the Sharpe ratio for the tangency portfolio on the minimum-variance frontier implies that the new tangency portfolio provides an extra return for a unit increase in standard deviation. We measure both the change and percentage change in the Sharpe ratio to quantitatively assess the economic significance of adding an IPO portfolio to a set of benchmark portfolios to gain diversification benefits. In addition to the Sharpe ratio, we also measure the diversification benefits by considering the risk (standard deviation) deduction due to the shift in the global minimum-variance (GMV) portfolio when adding an IPO portfolio to benchmark portfolios.
Finally, what types of IPOs offer large diversification improvements? We examine several IPO characteristics that have been studied in the IPO literature and complement these studies by providing an asset allocation perspective. IPOs in the 1980s backed by venture capitalists experienced less short-run underpricing, which Barry, Muscarella, Peavy, and Vetsuypens (1990) and Megginson and Weiss (1991) attribute to better monitoring and quality certification. Brav and Gompers (1997) find that long-run underperformance is limited to small nonventure backed IPOs. A strand of the literature also examines the relationship between underwriter reputation and underpricing and between reputation and long-run returns (see, for example, Logue (1973) , Beatty and Ritter (1986) , Booth and Smith (1986) , Carter and Manaster (1990) , Beatty and Welch (1996) , Carter, Dark, and Singh (1998) , and Logue, Rogalski, Seward, and Foster-Johnson (2002) ). However, the empirical results are mixed due to different sample periods and methodologies. Another usual taxonomy of IPOs is based on industries to proxy for technology type (see Mauer and Senbet (1992) , Benveniste, Ljungqvist, Wilhelm, and Yu (2003) for IPO initial returns; Ritter (1991) and Brav (2000) for the long-run performance of IPOs). To examine the relationship between IPO characteristics and the expansion of the investment opportunity set, we divide IPOs into different groups based on venture backing, underwriter reputation, and industry classification.
The above issues are intriguing in their own right to academics and also have pragmatic implications to both the issuance of IPO exchange traded funds (ETFs) or similar investment vehicles and mutual fund managers for IPO security selection and portfolio management. Our main findings can be summarized as follows. First, we compare the statistical and economic significance of the shifts in the mean-variance frontier for an investor who adds an IPO portfolio to a set of benchmark portfolios relative to an investor who invests only in a set of benchmark portfolios. To put the IPO market into perspective, the average monthly ratio of the IPO market value from the previous three years to the market value of non-IPO firms is only around 4%. However, we find that investing in a value-weighted IPO portfolio reliably improves the investment opportunity set, while investing in an equally weighted IPO portfolio does not. This implies that large IPOs are more likely to be associated with enlarging the investment opportunity set. In terms of the percentage change in the Sharpe ratio, adding a value-weighted IPO portfolio to a set of benchmark portfolios increases the Sharpe ratio of the tangency portfolio by 5.5%. On the other hand, consistent with the mean-variance spanning test results, adding an equally weighted IPO portfolio to a set of benchmark portfolios increases the Sharpe ratio of the tangency portfolio by only 2.50%.
Second, we divide IPOs into different groups based on whether they are venture capital backed, or whether they are associated with prestigious underwriters. Alternatively, the IPO sample is also sorted into nine different industries based on the classification of Ritter (1991), Spiess and Affleck-Graves (1995), and Brav (2000) . Using different types of IPO portfolios, we examine which of them help investors improve their investment opportunity set. IPOs backed by venture capitalists, IPOs with prestigious underwriters, and IPOs in the business services, computer, and health care industries allow investors to expand their investment opportunity set under both equally weighted and value-weighted schemes. The highest increase for the Sharpe ratio of the tangency portfolio after adding these IPO portfolios is 13.39% from the equally weighted one-year business services IPO portfolio.
Finally, we consider the sub-period 1980-1998 to avoid the impact of the Internet bubble period as a robustness check for our results. We find that the test statistics are more significant for the sub-period 1980-1998, but the main results do not change. We also use three IPO indexes, compiled by IPOX Schuster LLC, as IPO portfolios to test the mean-variance spanning hypothesis. We find that adding these value-weighted IPO indexes significantly expand the mean-variance frontier formed by the 25 size/book-to-market benchmark portfolios. Furthermore, to avoid possible extreme portfolio weights, it is more practicable to restrict the optimal weight of each portfolio to be between -1 and 1. The results based on restricted portfolio weights are also consistent with our main results.
There is one possible explanation for the findings that some IPO portfolios provide significant diversification benefits in terms of the expansion of the mean-variance frontier, which is based on the argument of incomplete spanning by stocks traded in the secondary market. Mauer and Senbet (1992) present a theory that IPO underpricing is a function of incomplete spanning of the IPO by secondary market assets and the degree of investor access to the IPO market, which reflects a primary risk premium. Extending the incomplete spanning argument could explain the result that adding an IPO portfolio with specific characteristics can significantly expand the mean-variance frontier because some specific IPO portfolios are not highly correlated with secondary market assets and thus provide diversification benefits.
Our empirical findings also imply that investors would be interested in investing in IPOs beyond the underpricing consideration and help explain the existence of investment vehicles specializing in IPO investment. Furthermore, our empirical results point out the likelihood of the issuance of IPO exchange traded funds because they can provide potential diversification gains relative to currently traded ETFs based on market capitalization and value/growth style.
The remainder of this paper is organized as follows. Section 2 provides the methods used to evaluate the mean-variance spanning. Section 3 describes the data and provides details of the procedures used for selecting the benchmark portfolios. Section 4 presents the empirical results. Section 5 concludes the paper.
Testing for and Measuring IPO Diversification Benefits
Mean-Variance Spanning Tests
Huberman shift is statistically significant can be tested using regression-based mean-variance spanning tests. We briefly describe the main statistical tests that we use to examine whether adding an IPO portfolio could significantly improve the investment opportunity set relative to a set of benchmark assets. For convenience, we follow the notations and treatment in Kan and Zhou (2001) . The details of the test statistics for mean-variance spanning tests are shown in Appendix A. 4 We denote by K the set of benchmark portfolios (non-IPO portfolios that an investor may hold) with return R 1t and by N the set of test assets (one calendar-time IPO portfolio) with return R 2t . We estimate the following model using ordinary least squares as 4 Our treatment for the mean-variance spanning tests is brief. For details we refer the readers to the comprehensive surveys by DeRoon and Nijman (2001) and Kan and Zhou (2001) . In addition, Kan and Zhou (2001) examine the finite sample properties and compare the statistical power for two types of mean-variance spanning tests, namely, the regression-based approach and stochastic discount factor based (SDF-based) approach.
Following Huberman and Kandel (1987) , the null spanning hypothesis is 
where and are the global minimum-variance of the benchmark assets and benchmark assets plus an IPO portfolio, respectively. is the slope of the asymptote of the mean-variance frontier for the benchmark assets, and is the slope of the tangency line of the mean-variance frontier for the benchmark portfolios plus an IPO portfolio. The first term measures the change of the GMV portfolios due to the addition of an IPO portfolio. The second term measures whether there is an improvement of the squared tangency slope due to adding an IPO portfolio to the set of benchmark Kan and Zhou (2001) report that the asymptotic tests have very good power in testing assets that can reduce the variance of the GMV portfolio, but have little power against test assets that can only improve the tangency portfolio. They therefore suggest a step-down procedure that requires us to first test If the rejection is due to the first test, we know that it is because the two tangency portfolios are very different. If the rejection is due to the second test, it is because the two GMV portfolios are very different. Figure 1 depicts the geometric interpretation of the step-down test using the equally weighted three-year IPO portfolio of the computer industry. The tests described so far assume that the returns are normally distributed and the error term in Equation (1) is homoskedastic. We also use a GMM Wald test to adjust for return non-normality and heteroskedasticity.
Measuring Diversification Gains of Adding IPO Investment
Based on the step-down test of Kan and Zhou (2001) , we could attribute the test significance for the expansion of the minimum-variance frontier to the shift of the tangency portfolio and/or the shift of the global minimum-variance portfolio. The next question is to assess the extent or economic significance of diversification gains when one adds an IPO portfolio to benchmark portfolios. To correspond to the step-down test, we will apply two measures, namely the Sharpe ratio and the risk deduction of the GMV portfolio, to assess IPO diversification benefits.
Modern portfolio theory suggests that the Sharpe ratio is a natural choice to measure the shift in the tangency portfolio. The Sharpe ratio measures the slope of the line from the risk-free rate to any portfolio in the mean-standard deviation plane. Bekaert and Urias (1996) suggest that one can assess the economic significance of the shift in the minimum-variance frontier by evaluating the change in the Sharpe ratio. Petrella (2005) also uses the Sharpe ratio to measure the diversification benefits of investing in European small cap stocks. A positive change in the Sharpe ratio after adding an IPO portfolio implies that the new tangency portfolio provides an extra return for a unit increase in standard deviation. We measure both the change and percentage change in the Sharpe ratio to assess the economic significance of adding an IPO portfolio to a set of benchmark portfolios to gain diversification benefits.
Another measure of diversification benefits is to consider the risk deduction due to the shift in the GMV portfolio when adding an IPO portfolio to benchmark portfolios. The measure is defined as the difference in standard deviation between the GMV portfolio computed from the benchmark portfolios and the GMV portfolio computed from the benchmark plus IPO portfolios. As Petrella (2005) points out, the risk deduction measure assumes that investors are only concerned with minimizing risk and do not care about returns. Though this assumption is pretty strong, the risk deduction measure is independent of the expected return estimation and it is more difficult to estimate an expected return than a variance or standard deviation (see Merton (1980) and Jorion (1985) ).
Data Description
Our sample The IPO portfolio used as a test asset in our mean-variance spanning tests is described as follows. For a given month, we form the one-year IPO portfolio by including all IPOs that went public during the prior 12 months. Similarly, we form the three-year IPO portfolio by including all IPOs that went public during the prior 36 months. 5 To avoid the impact of underpricing, we do not include the return from the first trading month when the firm just goes public. Figure 3 shows the relative market value of the three-year IPO portfolio to non-IPO firms. The average monthly ratio is 3.88% from 1980-2002, and the average for the period 1980-1998 is slightly less at 3.60%. We also find that the trend in this market value ratio is more consistent with the Nasdaq composite index trend rather than that for the S&P 500 index.
We further divide the IPO sample into venture capital backed IPOs and non-venture capital backed IPOs based on SDC's classification. We also partition our sample into IPOs associated with prestigious lead underwriters and IPOs without highly ranked lead underwriters based on whether the Carter and Manaster rank of the lead underwriter is greater than or equal to 8 (see Carter and Manaster (1990) ). The updated underwriter reputation rank is collected from Carter, Dark, and Singh (1998) and Loughran and Ritter (2004) . 6 The underwriter rank ranges from zero to nine based on the hierarchy of tombstone announcements. Finally, we sort IPOs into nine groups based on the industry classification provided by Ritter (1991), Spiess and Affleck-Graves (1995), and Brav (2000) (see Appendix B for detail). Panel A of Table 1 presents the returns and standard deviations of our different IPO portfolios. We find that the equally weighted venture backed IPO portfolios have higher mean returns and are riskier than the non-venture backed counterparts. However, the value-weighted venture backed IPO portfolios have lower mean returns but are riskier than their non-venture backed counterparts. We further notice that in general IPOs with prestigious lead underwriters perform much better and have higher risk than those with non-prestigious lead underwriters.
For the benchmark portfolios, we use five size and five book-to-market portfolios to form the 25 size and book-to-market portfolios of NYSE, AMEX, and Nasdaq stocks as described in French (1992, 1993) . Another motivation to use these benchmark portfolios is that quite a few exchange traded funds (ETFs) are based on market capitalization and value/growth classification. For instance, iShares Morningstar Index Fund Series, iShares Russell Index Fund Series, and iShares S&P Index Fund Series are usually based on market capitalization and value/growth category.
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To be included in the benchmark portfolios, a firm must have had stock prices in CRSP
for December of year t-1 and June of year t and COMPUSTAT book common equity for year t-1. Moreover, the firms must have been on COMPUSTAT for two years prior to year t to avoid backfill bias. To avoid the contamination problem in benchmark portfolios pointed out by Loughran and Ritter (2000), we do not include the firms that have appeared in our IPO portfolios.
Following Fama and French (1992) , we define BE as the COMPUSTAT book value of stockholders' equity, plus balance-sheet deferred taxes and investment credit (if available), minus the book value of preferred stock. Depending on availability, we use the redemption, liquidation or par value (in this order) to estimate the value of preferred stock. We also define ME as the market price of the stock times the number of shares outstanding. At the end of June each year from 1980-2002, the size (ME) and book-to-market (BE/ME) quintiles are created using only the NYSE stocks. Panel B of Table 1 presents the summary statistics of 25 size/book-to-market portfolios excluding firms that had IPOs in the past 12
months. Panel C of Table 1 presents the summary statistics of 25 size/book-to-market portfolios excluding firms that had IPOs in the past 36 months.
Mean-Variance Frontier Expansion from Adding IPO Investment
Full Sample Results
We test whether adding an IPO portfolio to a set of benchmark assets based on 25 size and book-to-market portfolios enlarges the investment opportunity set for mean-variance investors. weighted 1-year IPO portfolio and each of the 25 portfolios (Panel A of Table 3 ). The finding supports the statistical results in Table 2 . On the other hand, the evidence for the cases of 3-year IPO portfolios is not clear.
The previous mean-variance spanning tests only examine whether the expansion of the minimum-variance frontier is statistically significant. As Bekaert and Urias (1996) suggest, we can assess the economic significance of the shift in the minimum-variance frontier by evaluating the change in the Sharpe ratio. The Sharpe ratio, also known as the "reward to variability" ratio, measures the slope of the line from the risk-free rate to any portfolio in the mean-standard deviation plane (see Sharpe (1994) argues that portfolio choice can be separated into two steps: (1) the determination of the optimal tangency portfolio; (2) the construction of the mix between the risk-free asset and the optimal tangency portfolio, dependent on investors' preferences. Therefore, investors are more likely concerned with the change in the tangency portfolio than the global minimum-variance portfolio.
Earlier we show that when adding either an equally weighted one-year or three-year IPO portfolio, neither of them significantly expands the minimum-variance frontier based on the step-down test. In Table 2 , the percentage change in the Sharpe ratio for the tangency portfolio is 2.43% when adding the equally weighted one-year IPO portfolio and 2.65% when adding the equally weighted three-year IPO portfolio. 9 The risk deduction rate for the GMV portfolio is 0.00% and -0.28%, respectively. By contrast, adding a value-weighted one-year IPO portfolio significantly expands the minimum-variance frontier mostly due to a shift in the tangency portfolio. The percentage change in the Sharpe ratio for the tangency portfolio is 6.69%, much greater than 2.43% when adding an equally weighted one-year IPO portfolio. Furthermore, for one-year and three-year value-weighted IPO portfolios, we find a larger risk deduction on GMV portfolios with a rate of -0.29% and -0.57% as compared with the one-year and three-year equally weighted IPO portfolios.
When we look further at the change in the Sharpe ratio for the tangency portfolio, adding a value-weighted one-year IPO portfolio provides an extra return of 3.3%
((0.526-0.493)*100%) for a unit increase in standard deviation. However, adding an equally weighted one-year IPO portfolio only provides an extra return of 1.2%
((0.505-0.493)*100%) for a unit increase in standard deviation. The findings are consistent with the argument that the absolute change and the absolute percentage change in the Sharpe ratio are inversely related to the p-values associated with the first step-down test. Figure 4 shows that the expansion of the mean-variance frontier when adding the three-year value-weighted IPO portfolio is more apparent than adding the three-year equally weighted IPO portfolio. In summary, our empirical results suggest that investing in a value-weighted IPO portfolio can significantly improve a mean-variance investor's investment opportunity set. In other words, investing in large IPOs within one year after the offer significantly gains the diversification benefit. Also, the sources of the improvement for the mean-variance frontier are different between the one-year value-weighted IPO portfolio and three-year value-weighted IPO portfolio.
Results Based on Various IPO Characteristics
9 The complete results regarding the Sharpe ratios, and risk/return for tangency and GMV portfolios in Section 4 are available upon request.
Venture Capital Backed IPOs versus Non-Venture Capital Backed IPOs
Panel A of Table 4 presents the mean-variance spanning test results using venture capital backed and non-venture capital backed IPO portfolios separately. We reject the null hypothesis using the Wald test in both the equally weighted and value-weighted IPO portfolios regardless of the time horizon. 10 Using the step-down test, we find that the shift in the mean-variance frontier from adding either a value-weighted or an equally weighted venture backed IPO portfolio to the benchmark portfolios is due mainly to the change in the global minimum-variance portfolio rather than the change in the tangency portfolio. The percentage change in the standard deviation of the GMV portfolio is -1.13% for the three-year equally weighted case and -1.98% for the three-year value-weighted case, which further confirms the above results. One exception is that adding an equally weighted three-year venture backed IPO portfolio increases the Sharpe ratio for the tangency portfolio by 5.09%. The top graph in Figure 5 shows that the expansion of the mean-variance frontier from adding the value-weighted three-year venture backed IPO portfolio is due to the change in the global minimum-variance portfolio.
In the mean-variance spanning test results using a non-venture backed IPO portfolio, the Wald test rejects the null hypothesis in both the value-weighted one-year and three-year non-venture backed IPO portfolios. However, we cannot reject the null hypothesis for the equally weighted portfolios. Using the step-down test, we find that the shift in the mean-variance frontier when adding the value-weighted one-year or three-year non-venture backed IPO portfolio to the benchmark portfolios is largely due to the shift in the tangency portfolio. The percentage change in the Sharpe ratio for the tangency portfolio is around 10% when adding the value-weighted one-year IPO portfolio and around 5% when adding the value-weighted three-year IPO portfolio. The bottom graph of Figure 5 illustrates the result for the value-weighted three-year non-venture backed IPO portfolio. Therefore, investing in large non-venture backed IPOs especially within one year after the offering significantly improves investors' ability to diversify.
In general, our findings show that adding an IPO portfolio backed by venture capital can significantly improve the investment opportunity set for mean-variance investors, regardless of the different time horizons and portfolio weighting schemes. In contrast, a non-venture capital backed IPO portfolio can only improve the investment opportunity set under the value-weighting scheme.
IPO Portfolios Based on Lead Underwriter Reputation
Panel B of Table 4 shows the results of mean-variance spanning tests using portfolios composed of IPOs with prestigious lead underwriters and IPOs with non-prestigious lead underwriters. For IPOs associated with prestigious lead underwriters, the null hypothesis is rejected by the Wald test in both value-weighted and equally weighted IPO portfolios for one year and three years. Using the step-down test, the shift in the mean-variance frontier by adding either a value-weighted or an equally weighted one-year IPO portfolio to the benchmark portfolios is mainly due to the change in the tangency portfolio. The percentage change in the Sharpe ratio for the tangency portfolio is 7.10% when adding the equally weighted one-year IPO portfolio and 8.11% when adding the value-weighted one-year IPO portfolio. On the other hand, the shift in the mean-variance frontier by adding either a value-weighted or an equally weighted three-year IPO portfolio to the benchmark portfolios is due mainly to the change in the global minimum-variance portfolio, although the change in the tangency portfolio is also statistically significant. The percentage change in the Sharpe ratio for the tangency portfolio is 4.89% when adding the equally weighted three-year IPO portfolio and 5.30% when adding the value-weighted three-year IPO portfolio. In addition, the percentage change in the standard deviation of the GMV portfolio when adding equally and value-weighted IPO portfolios are both -0.57%. Thus, investing in IPOs associated with prestigious lead underwriters especially within one year after the offering significantly enhances the benefit of additional diversification. The top graph in Figure 6 shows that the value-weighted three-year IPO portfolio with prestigious lead underwriters is expanded due to the change in both the tangency and global minimum-variance portfolios.
For mean-variance spanning tests using IPOs with non-prestigious lead underwriters, the Wald test does not reject the null hypothesis for both value-weighted and equally weighted IPO portfolios regardless of the time horizon. In other words, investors cannot improve their investment opportunity set or gain significant diversification benefits by investing in IPOs with non-prestigious underwriters in addition to the 25 size/book-to-market portfolios. The bottom graph in Figure 6 shows that after adding the value-weighted three-year IPO portfolio, the mean-variance frontier is almost identical to the original minimum-variance frontier.
In a nutshell, we find that underwriter reputation has a large impact on the diversification benefits for including IPO stocks in one's portfolio. Investors who add an IPO portfolio associated with prestigious lead underwriters can significantly improve their investment opportunity set. However, adding an IPO portfolio without prestigious lead underwriters does not expand the minimum-variance frontier. Note that there is a strong positive correlation between the size of the offering and underwriter reputation. In particular, all large IPOs use prestigious lead underwriters.
IPO Portfolios Sorted by Industries
We also divide our IPO sample into nine industry portfolios based on Ritter (1991), Spiess and Affleck-Graves (1995), and Brav (2000) . We find that adding business services, computer, and health care industry IPO portfolios can reject the mean-variance spanning hypothesis using a Wald test in both the value-weighted and equally weighted portfolios regardless of the time horizon. 11 We report these findings in Panel C of Table 4 . We find that the sources for the mean-variance frontier expansion are different based on the step-down
Wald test. The frontier expansion after adding IPOs in either the business services industry or the computer industry is due to the shift in both the tangency and global minimum-variance (GMV) portfolios. The only exception is the case adding a value-weighted three-year IPO portfolio in the business services industry.
For the business services industry, there is a 13.39% increase in the Sharpe ratio for the tangency portfolio when adding the equally weighted one-year IPO portfolio and a 9.13%
increase when adding the value-weighted one-year IPO portfolio. We also find that the GMV portfolio risk deduction rates are -0.85% and -1.42% when adding equally and value-weighted three-year IPO portfolios. This implies that investment in IPOs in the business services industry after the offering could significantly gain diversification benefits.
For the computer industry, the percentage change in the Sharpe ratio for the tangency portfolio is 6.09% when adding the equally weighted one-year IPO portfolio and 8.55%
when adding the equally weighted three-year IPO portfolio. Furthermore, the GMV portfolio risk is reduced by 0.85% and 1.13% respectively when adding three-year equally weighted and value-weighted IPO portfolios. Therefore, investing in IPOs in the computer industry within three years after the offering significantly improves the diversification benefits. For IPOs in the health care industry, the frontier expansion is due mainly to the change in the global minimum-variance portfolio rather than the tangency portfolio. This finding is further confirmed by the risk deduction rate of GMV portfolios, ranging from -0.57% to -1.42%, after adding IPOs to the 25 size/book-to-market portfolios.
Robustness Check
The Internet Bubble
In 
IPOX Indexes
An Table 5 reports that these value-weighted IPO indexes significantly expand the minimum variance frontier generated by 25 size/book-to-market benchmark portfolios. Thus, these results are consistent with the results obtained from our value-weighted IPO portfolios.
Portfolio Weight Constraints
The previous mean-variance spanning tests examine whether the minimum-variance frontier expansion is statistically significant when no portfolio weight constraint is used. To avoid possible extreme portfolio weights, it would be more reasonable to restrict the optimal weight of each portfolio (IPO and the 25 benchmark portfolios) to be between -1 and 1, which is termed "the unit weight constraint." 13 Table 6 reports the optimal IPO portfolio weight and its corresponding Sharpe ratio for the full sample IPO portfolio and other five IPO portfolios that could significantly improve an investor's opportunity set. We show the empirical results for the case without a portfolio weight constraint and for the case with the unit weight constraint.
We find that the optimal weight for IPO portfolios is positive in all cases with or without restrictions. Therefore, the results imply that the portfolio weight constraint is not a main concern for our empirical finding. The optimal IPO portfolio weights and the corresponding Sharpe ratios decrease due to the introduction of the unit weight constraint.
In summary, our empirical findings are robust even using a more reasonable portfolio weight constraint between -1 and 1.
Discussion
After discussing our empirical results, we offer an incomplete spanning explanation to explain that the mean-variance frontier formed by benchmark portfolios can be expanded by adding an IPO portfolio. Mauer and Senbet (1992) investigate the role of the secondary market to explain IPO underpricing based on the incomplete spanning argument. In their framework, at the offering stage, IPOs are priced in the primary market populated by firms that may have short operating history and relatively few comparable firms in the secondary market. The secondary market helps establish the after-market clearing prices for IPOs. Mauer and Senbet (1992) argue that IPO underpricing is a function of incomplete spanning of the IPO by secondary market assets and the degree of investor access to the IPO market.
Extending the incomplete spanning argument beyond IPO underpricing, it may be used to explain the rejection for the mean-variance spanning hypothesis, that is, adding an incomplete spanning IPO portfolio can expand the mean-variance frontier formed by benchmark portfolios. The intuition is that an incomplete spanning IPO portfolio is not highly correlated with the secondary market assets and thus provides diversification benefits.
For example, prestigious lead underwriters are more likely to bring new successful technology firms to the market. These IPO firms are less likely to have perfect secondary market substitutes, making them more likely provide diversification benefits. Similarly, venture capitalists are also more likely to identify successful technology firms that are hard to value by secondary market assets. Thus, these successful technology IPO firms are more likely to offer diversification benefits.
Next, we point out implications for the empirical results that an IPO portfolio can help enlarge the investment opportunity set relative to an investment in a set of benchmark portfolios sorted by firm size and book-to-market ratio. One straightforward implication is that if one issues exchange traded funds (ETFs) using IPOs as a new asset class, these IPO ETFs could potentially add diversification benefits to currently traded ETFs based on the size and book-to-market classification. For example, in current ETF markets, iShares
Morningstar Index Fund Series, iShares Russell Index Fund Series, and iShares S&P Index Fund Series are based on market capitalization and value/growth style. Another implication is that there should be demand for current investment vehicles specializing in IPO investment such as IPO mutual funds and unit trusts because investors can easily access to primary market portfolios and gain diversification benefits.
Conclusion
This paper investigates the IPO market from the perspective of asset allocation for the period 1980-2002. We employ the mean-variance spanning tests to examine whether adding IPOs provides significant diversification benefits when added to a set of commonly used benchmark portfolios sorted by firm size and book-to-market ratio. To our knowledge, our study is the first to use the idea of mean-variance spanning in the IPO context.
The empirical results of this paper are summarized as follows. First, investors who invest in a value-weighted IPO portfolio are able to enlarge their investment opportunity set relative to an investment in a set of benchmark portfolios sorted by firm size and book-to-market ratio. In contrast, investing in an equally weighted IPO portfolio does not improve the investment opportunity set. Because institutional investors and mutual fund managers care more about value-weighted portfolios than equally weighted portfolios, the results show that investing in large IPOs expands the investment opportunity set and improves asset allocation.
Second, value-weighted and equally weighted venture backed IPO portfolios and IPO portfolios with prestigious lead underwriters significantly improve an investor's investment opportunity set. These results are significant for both one-year and three-year holding period.
Third, based on the sort by industry, we find that investors can improve their investment opportunity set by holding IPO portfolios in the business services, computer, or health care industry. These three subgroups exhibited consistent results in both one-year and three-year portfolios regardless of the weighting scheme. Fourth, the Internet Bubble has only a minor influence on our results. Although for some groups of IPO portfolios the Wald statistics from 1980-1998 are larger than the statistics of the same groups from 1980-2002, the main conclusions do not change qualitatively. Another robustness check is adding IPO indexes compiled by IPOX Schuster LLC, which also significantly expands the minimum variance frontier formed by 25 size/book-to-market benchmark portfolios. Our empirical findings are robust even when using a more reasonable portfolio weight constraint between -1 and 1.
Our empirical findings are intriguing due to the fact that although the average monthly ratio of market value of IPOs from the prior 3 years to the market value of non-IPO firms is only around 4%, the diversification benefits are economically and statistically significant based on the mean-variance spanning tests and the percentage change in the Sharpe ratios.
Furthermore, because investors can expand their investment opportunity set by adding an IPO portfolio to a set of portfolios sorted by firm size and book-to-market ratio, IPOs with certain characteristics, such as the involvement of venture capital and association with prestigious lead underwriters, are worth investing in. Since numerous exchange traded funds come to the market based on market capitalization and value/growth category, our empirical results imply that the issuance of IPO exchange traded funds can provide potential diversification gains relative to currently traded ETFs based on market capitalization and value/growth style. Our study also provides evidence that there should be demand for investment vehicles specializing in IPO investment such as IPO mutual funds and unit trusts. 
with the estimators of B and Σ are and
Under the normality assumption, we have
Following Huberman and Kandel (1987) , the null hypothesis of "spanning" is
We can write this null hypothesis as 
Finite Sample Mean-Variance Spanning Tests
The exact finite sample distribution of the likelihood ratio test under the null, as Huberman and Kandel (1987) and Jobson and Korkie (1989) also show, is
where
Step-Down Asymptotic Wald Test Statistics
Based on Kan and Zhou (2001) , the step-down procedure first tests 
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Based on Kan and Zhou (2001) , Equations (9A) and (10A) can also be rewritten using the similar notation of the finite sample step-down F tests as (see Kan and Zhou (2001) for details) 
Mean-Variance Spanning Tests under Non-Normality and Heteroskedasticity
The GMM Wald test is
where the moment condition is . Furthermore, new S T is different from S T of the joint test in Equation (15A) since X for the second step-down test has no intercept term (i.e., a vector of ones). Finally, we note that both step-down GMM Wald test statistics are distributed as chi-square with N degrees of freedom.
The details on how the change in matrix A T is made are shown as follows. Based on Kan and Zhou (2001) , A T is the consistent estimate for . For the first step-down
For the second step-down test (testing
where new X is different from X in Equation (17A), since there is no intercept term in the regression equation estimated.
Appendix B: SIC Codes for Industry Classification
The classification of industries is based on Ritter (1991), Spiess and Affleck-Graves (1995), and Brav (2000) . 1 9 7 8 1 9 7 9 1 9 8 0 1 9 8 1 1 9 8 2 1 9 8 3 1 9 8 4 1 9 8 5 1 9 8 6 1 9 8 7 1 9 8 8 1 9 8 9 1 9 9 0 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 1 9 9 9 2 0 0 0 
Figure 3 Market Indices and the Ratio of IPO/Non-IPO Firm Market Value
Market indices are the S&P 500 index and Nasdaq composite index. The IPO portfolio is a three-year IPO portfolio that includes all IPOs within the last 36 months. The ratio is the total market value of the three-year IPO portfolio divided by the total market value of the non-IPO firms in CRSP within the last 36 months. The market value is defined as the market price of the stock times the number of shares outstanding. 
